Srinivas Reddy Mamidi, SVP & Global Head – Enterprise Accounts, is one of Aragen’s first 5 employees and has been part of the company’s journey since its inception. Over 25 years with Aragen, Srinivas has grown with the organisation, taking on diverse responsibilities across Informatics, Bio-IT and Business Development before moving into leadership roles in Europe and Enterprise Accounts.
Today, Srinivas leads Business Development for Enterprise Accounts, playing a key role in strengthening Aragen’s strategic partnerships with large pharmaceutical companies across three businesses of Aragen in Discovery, Small Molecule-CDMO and Biologics. Srinivas works closely with Big Pharma customers to identify customer needs and develop opportunities, shape business strategies and create innovative engagement models that bring together Aragen’s capabilities across three businesses.
Based in the Netherlands, Srinivas brings 27+ years of experience across the CRO and life sciences industry, supported by a background in Pharmaceutical Sciences and Bioinformatics and an Executive MBA from IMD Business School, Lausanne.
When I joined GVK Bio 25 years ago, we were a small team with just one chemistry lab. Since then, I have had the privilege of witnessing our transformation into Aragen, with new facilities, expanding scientific capabilities, and a growing global presence.
Being the first employee makes this journey especially meaningful to me. Over the years, I have supported Aragen through different stages of its growth, from navigating regulatory requirements to helping shape the infrastructure that supports our people and science today.
What makes me proudest is that even as we have grown, our foundation has remained strong: excellence, partnership and a commitment to improving lives. Aragen has given me continuous opportunities to learn, contribute and grow alongside the organisation. For me, it has always been more than a workplace. It is a place I have been proud to help build and call home.
